ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 86371 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 86371; 2) Community: the network communities that were significantly associated with the response to NSC 86371; 3) Molecule: the relationships between components within communities and NSC 86371; 4) MDR: the compounds that were significantly associated with the NSC 86371.

NSC Compound Enrichment Correlation
NSC 708416 Null 0.0228506033927957 0.21132693
NSC 709100 Null 0.0228506033927957 0.36767703
NSC 728040 2-[4-(methoxy)phenyltio]-3-phenyl-5,7-diamino quinoxaline 0.0228506033927957 0.38221942
NSC 728132 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-3,4-dichlorobenzene 0.0228506033927957 0.42182
NSC 743432 2-{5-[4-(5-{4-[6-morpholino-1H-benzo[d]imidazole-2-yl]phenoxy}pentyl)piperazino]pentyl}-2,3-dihydro-1H-benzo[de]isoquinoline-1,3-dione 0.0228506033927957 0.50203577
NSC 720374 1-(4-nitrophenyl)-3-methyl-6,7-methylenedioxy-isoquinoline 0.0235234559682126 0.079225457
NSC 227279 1,4-Naphthalenedione, 5,8-dihydroxy-2,3-bis(hydroxymethyl)- 0.023523455968213 0.33634533
NSC 301457 Cycloalkannin 0.023523455968213 0.33319115
NSC 331935 CHALCONE ANALOG 0.023523455968213 0.49072871
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.023523455968213 0.46619622
Total:139  Current:84    [First] [Prev] [Next] [Last]